Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) – the first and only cleared for ...

Kestra will be located at Booth 2119, where attendees can experience the ASSURE system firsthand, explore the Cardiac Recovery System platform through an immersive multimedia experience, and review ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) ...

Implicity, a leader in remote patient monitoring and cardiac data management solutions, today revealed new research presented at the 2026 European Heart Rhythm Association Congress (EHRA) examining ...

The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate AI-based ECG Algorithms The collaboration is focused on building next-generation, ...

LOS ANGELES, CA - March 25, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) recently announced a collaboration with Mount Sinai aimed at advancing artificial intelligence-driven electrocardiogram ...

Recent developments of interest in cardiovascular medicine ...

AliveCor announced today that it has received CE mark in Europe for its Kardia 12L electrocardiogram (ECG) system.

The wearable ECG monitors market is witnessing significant growth, poised to expand from $4.78 billion in 2025 to $5.9 billion in 2026, at a compound annu ...

Sophia Antipolis: An artificial intelligence (AI)-based method for interpreting ECGs performed better than standard approaches in detecting occlusive myocardial infarction (MI), according to a study ...